期刊文献+

大剂量伐昔洛韦治疗带状疱疹有效性和安全性的临床观察 被引量:9

Clinical observation on efficacy and safety of high dose valaciclovir in the treatment of herpes zoster
下载PDF
导出
摘要 目的观察大剂量伐昔洛韦治疗带状疱疹的有效性和安全性。方法按照治疗方式的不同将75例带状疱疹患者分为观察组和对照组,观察组予大剂量伐昔洛韦片;对照组予小剂量伐昔洛韦片,于第4、7、10、14天观察疗效和不良反应,皮疹消退后1个月随访后遗神经痛的发生情况。结果两组患者均在第4天开始皮疹评分下降,但第4、7、10天观察组的皮疹评分比对照组更低;观察组(第4天)NRS评分下降较对照组(第7天)要早,观察组第4天及以后疼痛均较对照组减轻明显(P<0.05)。14 d后观察组皮疹的改善与对照组相比无显著性差异,但疼痛的减轻优于对照组(P<0.05)。观察组后遗神经痛发生率(5.26%)低于对照组(21.62%)(P<0.05)。观察组和对照组分别出现4例和3例不良反应,均为轻到中度。结论大剂量伐昔洛韦治疗带状疱疹可加快皮疹消退,迅速缓解急性期疼痛,并有效预防后遗神经痛的发生。 Objective To observe the efficacy and safety of high dose valaciclovir in the treatment of herpes zoster.Methods According to different treatment methods,75 patients with herpes zoster were divided into observation group and control group.The observation group was given high dose valaciclovir tablets,the control group was treated with low dose valaciclovir,and the efficacy and adverse reactions were observed on the 4th,7th,10th and 14th days.The incidence of postherpetic neuralgia was followed up 1 month after the rash subsided.Results The scores of the rash in both groups decreased at the 4th day,but the scores of the rash in the observation group at the 4th,7th and 10th day were lower than that in the control group(P<0.05).The NRS scores of the observation group(4th d)decreased earlier than that of the control group(7th d),and the pain of the observation group decreased significantly compared with that of the control group at the 4th day and after(P<0.05).After 14 days,the resolution of the rash in the observation group was not significantly different from that in the control group,but the reduction of pain was better than that in the control group(P<0.05).The incidence of postherpetic neuralgia in the observation group(5.26%)was lower than that in the control group(21.62%)(P<0.05).There were 4 and 3 adverse reactions in the observation group and the control group,all of which were mild to moderate.Conclusion The treatment of herpes zoster with high dose of valaciclovir can accelerate the resolution of the rash,quickly relieve acute pain,and effectively prevent the occurrence of postherpetic neuralgia.
作者 马立娟 赵尚懿 顾礼忠 MA Li-juan;ZHAO Shang-yi;GU Li-zhong(Dermatology department of Tianjin Gong’an Hospital,Tianjin 300042,China)
出处 《中国处方药》 2020年第3期94-96,共3页 Journal of China Prescription Drug
关键词 伐昔洛韦 带状疱疹 有效性 安全性 Valaciclovir Herpes zoster Efficacy Safety
  • 相关文献

参考文献6

二级参考文献36

  • 1赵俊颖,金爱琼,何小明,朱明颖.伐昔洛韦治疗三叉神经带状疱疹的临床观察[J].临床口腔医学杂志,2005,21(6):347-348. 被引量:3
  • 2贾冬梅,苏海辉,张颖,李莉莉,孙颖,罗庆录.更昔洛韦治疗带状疱疹多中心开放研究[J].临床皮肤科杂志,2006,35(11):743-743. 被引量:27
  • 3李家泰,临床药理学,1998年,741页
  • 4Ormrod D,Goa K.Valaciclovir:a review of its use in the management of herpes zoster[J].Drugs,2000,59(6):1317-1340.
  • 5Lin WR,Lin HH,Lee SS,et al.Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster[J].J Microbiol Immunol Infect,2001,34(2):138-142.
  • 6Weller S,Blum MR,Doucette M,et al.Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteers[J].Clin Pharmacol Ther,1993,54(6):595-605.
  • 7Odom RB, James WD, Berger TG, et al. Andrew's diseases of skin [ M ]. 9th ed. Beijing: Science press, 2004,472- 475.
  • 8Waller S, Btum MR, Douoette M, et al. Pharmamkinetics of the acyclovir pro-drug valaciclovir after escalating sin- gle-and muhi-pledose administration to normal volunteers [ J ]. Clin Pharmacol Ther, 1993,54 ( 6 ) : 595- 605.
  • 9李成宾,李芸.加味龙胆泻肝汤治疗带状疱疹60例[J].光明中医,2010,25(5):800-801. 被引量:9
  • 10林燕,郭晓宇,栾杨.带状疱疹的中成药及民间偏方疗法[J].中国临床医生杂志,2011,39(8):20-22. 被引量:6

共引文献452

同被引文献89

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部